ENDOLOGIX INC's ticker is ELGX and the CUSIP is 29266S106.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $69,000 | -99.7% | 14,138 | -99.6% | 0.00% | -100.0% |
| Q1 2017 | $23,457,000 | +25.2% | 3,239,894 | -1.1% | 0.02% | +14.3% |
| Q4 2016 | $18,734,000 | -48.7% | 3,275,241 | +14.8% | 0.02% | -48.8% |
| Q3 2016 | $36,526,000 | +2.7% | 2,853,606 | -0.0% | 0.04% | -2.4% |
| Q2 2016 | $35,571,000 | +46.8% | 2,854,779 | -1.5% | 0.04% | +44.8% |
| Q1 2016 | $24,234,000 | -2.1% | 2,898,788 | +16.0% | 0.03% | 0.0% |
| Q4 2015 | $24,745,000 | -0.6% | 2,499,503 | +23.1% | 0.03% | -3.3% |
| Q3 2015 | $24,889,000 | -22.9% | 2,030,102 | -3.5% | 0.03% | -11.8% |
| Q2 2015 | $32,282,000 | -10.6% | 2,104,455 | -0.6% | 0.03% | -10.5% |
| Q1 2015 | $36,125,000 | +12.0% | 2,116,279 | +0.3% | 0.04% | +11.8% |
| Q4 2014 | $32,256,000 | +44.5% | 2,109,607 | +0.2% | 0.03% | +36.0% |
| Q3 2014 | $22,326,000 | -29.9% | 2,106,243 | +0.6% | 0.02% | -30.6% |
| Q2 2014 | $31,833,000 | +18.6% | 2,092,872 | +0.3% | 0.04% | +12.5% |
| Q1 2014 | $26,844,000 | -4.3% | 2,085,748 | +29.7% | 0.03% | -8.6% |
| Q4 2013 | $28,056,000 | +24.6% | 1,608,721 | +15.3% | 0.04% | +12.9% |
| Q3 2013 | $22,519,000 | +120.7% | 1,395,216 | +81.6% | 0.03% | +93.8% |
| Q2 2013 | $10,205,000 | – | 768,410 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|